Regulus Therapeutics Inc. Company Name:
RGLS Stock Symbol:
NASDAQ Market:
Regulus Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Regulus Therapeutics Reports Second Quarter 2022 Financial Results and Recent Updates PR Newswire IND accepted and first subject dosed in the Phase 1 Single-Ascending Dose (SAD) study of RGLS8429 for the treatment of Autosomal Dominant Polycystic Kidney Disease (AD...
Regulus Therapeutics Announces Timing for Second Quarter 2022 Financial Results Webcast and Conference Call PR Newswire SAN DIEGO , Aug. 4, 2022 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery...
Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) PR Newswire SAN DIEGO , June 21, 2022 /PRNewswire/ -- Regulus Therapeutics Inc . (Nasdaq: ...